[1] Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol,2013,10: 686-690.
[2] Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol,2009,50: 204-210.
[3] Ahmed M. Non-alcoholic fatty liver disease in 2015. World J Hepatol,2015,7: 1450-1459.
[4] Oniki K, Saruwatari J, Izuka T, et al. Influence of the PNPLA3 rs738409 polymorphism on non-alcoholic fatty liver disease and renal function among normal weight subjects. PLoS One,2015,10: e0132640.
[5] Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol,2007,47:89-116.
[6] Mitsuishi Y, Motohashi H, Yamamoto M. The Keap1-Nrf2 system in cancers: stress response and anabolic metabolism. Front Oncol, 2012, 2: 200.
[7] Kansanen E, Kuosmanen SM, Leinonen H, et al. The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer. Redox Biol, 2013,1: 45-49.
[8] Loboda A, Damulewicz M, Pyza E, et al. Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci, 2016,73: 3221-3247.
[9] Tang W, Jiang YF, Ponnusamy M, et al. Role of Nrf2 in chronic liver disease. World J Gastroenterol, 2014,20: 13079-13087.
[10] Chambel SS, Santos-Goncalves A, Duarte TL. The Dual Role of Nrf2 in nonalcoholic fatty liver disease: regulation of antioxidant defenses and hepatic lipid metabolism. International BR,2015,2015: 597134.
[11] Prasad KN. Simultaneous activation of Nrf2 and elevation of dietary and endogenous antioxidant chemicals for cancer prevention in humans. J Am Coll Nutr, 2016,35: 175-184.
[12] Song JS, Kim EK, Choi YW, et al. Hepatocyte-protective effect of nectandrin B, a nutmeg lignan, against oxidative stress: Role of Nrf2 activation through ERK phosphorylation and AMPK-dependent inhibition of GSK-3beta. Toxicol Appl Pharmacol,2016,307:138-149.
[13] Scapagnini G, Vasto S, Abraham NG, et al. Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders. Mol Neurobiol, 2011,44: 192-201.
[14] Li W, Ma F, Zhang L, et al. S-Propargyl-cysteine exerts a novel protective effect on methionine and choline deficient diet-induced fatty liver via Akt/Nrf2/HO-1 pathway. Oxid Med Cell Longev, 2016,2016:4690857.
[15] Cui Y, Wang Q, Yi X, et al. Effects of fatty acids on CYP2A5 and Nrf2 expression in mouse primary hepatocytes. Biochem Genet, 2016,54: 29-40.
[16] Wang C, Cui Y, Li C, et al. Nrf2 deletion causes "benign" simple steatosis to develop into nonalcoholic steatohepatitis in mice fed a high-fat diet. Lipids Health Dis, 2013,12:165.
[17] Kamisako T, Tanaka Y, Kishino Y, et al. Role of Nrf2 in the alteration of cholesterol and bile acid metabolism-related gene expression by dietary cholesterol in high fat-fed mice. J Clin Biochem Nutr, 2014,54: 90-94.
[18] Yan C, Sun W, Wang X, et al. Punicalagin attenuates palmitate-induced lipotoxicity in HepG2 cells by activating the Keap1-Nrf2 antioxidant defense system. Mol Nutr Food Res, 2016, 60: 1139-1149.
[19] Valdecantos MP, Prieto-Hontoria PL, Pardo V, et al. Essential role of Nrf2 in the protective effect of lipoic acid against lipoapoptosis in hepatocytes. Free Radic Biol Med, 2015,84:263-278.
[20] Ahmed SM, Luo L, Namani A, et al. Nrf2 signaling pathway: Pivotal roles in inflammation. Biochim Biophys Acta, 2017,1863: 585-597.
[21] Benetti E, Chiazza F, Patel NS, et al. The NLRP3 Inflammasome as a novel player of the intercellular crosstalk in metabolic disorders. Mediators Inflamm, 2013,2013:678627.
[22] Strowig T, Henao-Mejia J, Elinav E, et al. Inflammasomes in health and disease. Nature, 2012,481: 278-286.
[23] Liu X, Zhou W, Zhang X, et al. Dimethyl fumarate ameliorates dextran sulfate sodium-induced murine experimental colitis by activating Nrf2 and suppressing NLRP3 inflammasome activation. Biochem Pharmacol,2016,112:37-49.
[24] Ka SM, Lin JC, Lin TJ, et al. Citral alleviates an accelerated and severe lupus nephritis model by inhibiting the activation signal of NLRP3 inflammasome and enhancing Nrf2 activation. Arthritis Res Ther, 2015,17:331.
[25] Liu X, Wang T, Liu X, et al. Biochanin A protects lipopolysaccharide/D-galactosamine-induced acute liver injury in mice by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation. Int Immunopharmacol,2016,38:324-331.
[26] He L, Peng X, Zhu J, et al. Mangiferin attenuate sepsis-induced acute kidney injury via antioxidant and anti-inflammatory effects. Am J Nephrol,2014,40: 441-450.
[27] Xu J, Kulkarni SR, Donepudi AC, et al. Enhanced Nrf2 activity worsens insulin resistance, impairs lipid accumulation in adipose tissue, and increases hepatic steatosis in leptin-deficient mice. Diabetes,2012,61: 3208-3218.
[28] DeNicola GM, Karreth FA, Humpton TJ, et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature,2011,475: 106-109.
[29] Kappos L, Gold R, Miller DH, et al. Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Lancet, 2008,372: 1463-1472. |
